FDA Clears SQI Multiplex Platform, Rheumatoid Arthritis Assay - Congoo

|

|

News

Media & Advertising

TRADE

FDA Clears SQI Multiplex Platform, Rheumatoid Arthritis Assay

Have an interest in this Story?
Sign Up for Real-Time email updates

GenomeWeb | November 02, 2009

NEW YORK (GenomeWeb News) â?? SQI Diagnostics today said that the US Food and Drug Administration has cleared for marketing its SQiDworks multiplex diagnostics platform and IgXPlex rheumatoid arthritis assay. The SQiDworks automated platform uses the firm's IgXPlex technology to allow multiplexed me...

Read Full Article

Leave a Comment:

You must be logged in to leave a comment Log in | Register

Most Read World Articles

DA MP killed in car crash - News24.com

29 dead, dozens missing, 245 rescued after ferry sinks in Indonesia - Tehran Times

Residents put on a brave face after shock flooding - Irish Independent

Hearings begin in UK Iraq war inquiry - CNN

'He was brave as a warrior' - Chicago Tribune

Featured Members

Niladri Roy
Manager-International Marketing
Computer Services

Martin P. Lee
Associate Lecturer
Knowledge Management

View more profiles

Access dozens of premium and subscriptions sites Free! Download now.

Advertise | Build a News Circle | Get News Briefings | Congoo News Home | Get the Netpass

About Congoo | Terms | Privacy | Need Help? | Site Map

Copyright ©2009 Congoo.com. All Rights Reserved.